Carson Wealth (CWM LLC)’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
VPM
VCM
AC
Carson Wealth (CWM LLC)'s PTCT Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its PTC Therapeutics (PTCT) stake by 2.3% in Q1 2026, selling an estimated $29.3K and leaving 17,891 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1435.
Carson Wealth (CWM LLC) first reported a position in PTCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.39M in Q4 2025. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.
- Carson Wealth (CWM LLC) held 17,891 shares of PTC Therapeutics worth $1.22M as of Q1 2026.
- Carson Wealth (CWM LLC) sold 414 PTC Therapeutics shares in Q1 2026, an estimated $29.3K.
- PTC Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1435 holding.
- Carson Wealth (CWM LLC) first reported a position in PTC Therapeutics in Q4 2021 and has held it in 18 quarters since.
- Carson Wealth (CWM LLC)'s PTC Therapeutics position peaked at $1.39M in Q4 2025.
- 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.